Ether

Ether

SCHEMBL21144482

C/C=C\c1ccccc1OP(=O)(O)O.CCOCC

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 5/20 0.55
INPPL1 O15357 3/20 0.41
INPP5A Q14642 3/20 0.41
INPP5B P32019 2/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
PDE3A Q14432 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NFE2L2 Q16236 2/20 0.38
LMNA P02545 4/20 0.36
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ATM Q13315 1/20 0.36
TFEB P19484 1/20 0.36
AKT1 P31749 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13158806 0.91 SRC (0.66) SRCINPPL1INPP5AINPP5BALDH1A1
Ether SCHEMBL22721324 0.86 SRC (0.53) SRCINPPL1INPP5AINPP5BALDH1A1
SCHEMBL406912 0.80 SRC (0.60) SRCINPPL1INPP5AINPP5BALDH1A1
SCHEMBL7210051 0.77 SRC (0.46) SRCKDM4EMEN1KMT2ANFE2L2
SCHEMBL7210055 0.77 SRC (0.46) SRCKDM4EMEN1KMT2ANFE2L2
Ether SCHEMBL21110865 0.77 MEN1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
Phosphoric Acid SCHEMBL21144485 0.76 HTT (0.45) SRCALDH1A1KDM4EMEN1KMT2A
Ether SCHEMBL21111047 0.75 MEN1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL13158799 0.75 SRC (0.62) SRCINPPL1INPP5AINPP5BALDH1A1
SCHEMBL3994776 0.73 SRC (0.64) SRCINPPL1INPP5AINPP5BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578028-B2 Surfactant composition DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2023-02-14 US claimed
WO-2021198866-A1 BLUE CATHODIC ELECTRODEPOSITION (CED) COATING COMPOSITION KANSAI NEROLAC PAINTS LIMITED (IN) 2021-10-07 WO claimed
US-20200331830-A1 SURFACTANT COMPOSITION DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2020-10-22 US claimed
US-20190217265-A1 SURFACTANT COMPOSITION DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2019-07-18 US claimed
WO-2021198866-A1 BLUE CATHODIC ELECTRODEPOSITION (CED) COATING COMPOSITION KANSAI NEROLAC PAINTS LIMITED (IN) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578028-B2 Surfactant composition CHRM1, DEGS1, ASH2L SRC 3879/4885INPPL1 2471/4885INPP5A 3806/4885
US-20200331830-A1 SURFACTANT COMPOSITION CHRM1, DEGS1, ASH2L SRC 3879/4885INPPL1 2471/4885INPP5A 3806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.